Song Shiyu, Vuai Miza S, Zhong Mintao
1Department of Medical Microbiology, Dalian Medical University, 9 Western Section, Lvshun South Road, Lvshunkou District, Dalian, 116044 China.
2Department of Natural Science, State University of Zanzibar (SUZA), P.O Box 146, Zanzibar, Tanzania.
Infect Agent Cancer. 2018 Mar 15;13:9. doi: 10.1186/s13027-018-0180-y. eCollection 2018.
In recent decades, bacteria's therapeutic role has aroused attention in medicinal and pharmaceutical research. While bacteria are considered among the primary agents for causing cancer, recent research has shown intriguing results suggesting that bacteria can be effective agents for cancer treatment - they are the perfect vessels for targeted cancer therapy. Several bacterial strains/species have been discovered to possess inherent oncolytic potentials to invade and colonize solid tumors in vivo. The therapeutic strategy of using bacteria for treating cancer is considered to be effective; however, the severe side effects encountered during the treatment resulted in the abandonment of the therapy. State-of-the-art genetic engineering has been recently applied to bacteria therapy and resulted in a greater efficacy with minimum side effects. In addition, the anti-cancer potential of tumor-targeting bacteria through oral administration circumvents the use of the intravenous route and the associated adverse effects. This review aims to provide a comprehensive summary of the latest literature on the role of bacteria in cancer treatment.
近几十年来,细菌的治疗作用在医学和制药研究中引起了关注。虽然细菌被认为是引发癌症的主要因素之一,但最近的研究显示了有趣的结果,表明细菌可以成为癌症治疗的有效手段——它们是靶向癌症治疗的理想载体。已发现几种细菌菌株/物种具有内在的溶瘤潜力,能够在体内侵袭并定植于实体瘤。利用细菌治疗癌症的策略被认为是有效的;然而,治疗过程中遇到的严重副作用导致该疗法被放弃。最近,先进的基因工程已应用于细菌治疗,并在副作用最小的情况下取得了更高的疗效。此外,通过口服给药的肿瘤靶向细菌的抗癌潜力避免了静脉途径的使用及其相关的不良反应。本综述旨在全面总结关于细菌在癌症治疗中作用的最新文献。